Findings of a trial of a drug aimed at treating advanced oesophageal – or gullet – cancer could lead to a new treatment approach for a sub-group of patients with this kind of cancer.

The University of Aberdeen was involved in a UK wide study to see if the drug gefitinib – already used in lung cancer – could help treat oesophageal cancer.

The Cancer Oesophagus Gefitinib trial was the first study conducted in oesophageal cancer patients whose disease had progressed after chemotherapy.

Continue Reading

READ FULL ARTICLE Curated publisher From Medical Express